Cargando…

A latent cardiomyocyte regeneration potential in human heart disease

Cardiomyocytes in the adult human heart show a regenerative capacity, with an annual renewal rate around 0.5%. Whether this regenerative capacity of human cardiomyocytes is employed in heart failure has been controversial. Using retrospective (14)C birth dating we analyzed cardiomyocyte renewal in p...

Descripción completa

Detalles Bibliográficos
Autores principales: Derks, Wouter, Rode, Julian, Collin, Sofia, Rost, Fabian, Heinke, Paula, Hariharan, Anjana, Pickel, Lauren, Simonova, Irina, Lázár, Enikő, Graham, Evan, Jashari, Ramadan, Andrä, Michaela, Jeppsson, Anders, Salehpour, Mehran, Alkass, Kanar, Druid, Henrik, Kyriakopoulos, Christos P., Taleb, Iosif, Shankar, Thirupura S., Selzman, Craig H., Sadek, Hesham, Jovinge, Stefan, Brusch, Lutz, Frisén, Jonas, Drakos, Stavros, Bergmann, Olaf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10515906/
https://www.ncbi.nlm.nih.gov/pubmed/37745322
http://dx.doi.org/10.1101/2023.09.14.557681
_version_ 1785109041990598656
author Derks, Wouter
Rode, Julian
Collin, Sofia
Rost, Fabian
Heinke, Paula
Hariharan, Anjana
Pickel, Lauren
Simonova, Irina
Lázár, Enikő
Graham, Evan
Jashari, Ramadan
Andrä, Michaela
Jeppsson, Anders
Salehpour, Mehran
Alkass, Kanar
Druid, Henrik
Kyriakopoulos, Christos P.
Taleb, Iosif
Shankar, Thirupura S.
Selzman, Craig H.
Sadek, Hesham
Jovinge, Stefan
Brusch, Lutz
Frisén, Jonas
Drakos, Stavros
Bergmann, Olaf
author_facet Derks, Wouter
Rode, Julian
Collin, Sofia
Rost, Fabian
Heinke, Paula
Hariharan, Anjana
Pickel, Lauren
Simonova, Irina
Lázár, Enikő
Graham, Evan
Jashari, Ramadan
Andrä, Michaela
Jeppsson, Anders
Salehpour, Mehran
Alkass, Kanar
Druid, Henrik
Kyriakopoulos, Christos P.
Taleb, Iosif
Shankar, Thirupura S.
Selzman, Craig H.
Sadek, Hesham
Jovinge, Stefan
Brusch, Lutz
Frisén, Jonas
Drakos, Stavros
Bergmann, Olaf
author_sort Derks, Wouter
collection PubMed
description Cardiomyocytes in the adult human heart show a regenerative capacity, with an annual renewal rate around 0.5%. Whether this regenerative capacity of human cardiomyocytes is employed in heart failure has been controversial. Using retrospective (14)C birth dating we analyzed cardiomyocyte renewal in patients with end-stage heart failure. We show that cardiomyocyte generation is minimal in end-stage heart failure patients at rates 18–50 times lower compared to the healthy heart. However, patients receiving left ventricle support device therapy, who showed significant functional and structural cardiac improvement, had a >6-fold increase in cardiomyocyte renewal relative to the healthy heart. Our findings reveal a substantial cardiomyocyte regeneration potential in human heart disease, which could be exploited therapeutically.
format Online
Article
Text
id pubmed-10515906
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cold Spring Harbor Laboratory
record_format MEDLINE/PubMed
spelling pubmed-105159062023-09-23 A latent cardiomyocyte regeneration potential in human heart disease Derks, Wouter Rode, Julian Collin, Sofia Rost, Fabian Heinke, Paula Hariharan, Anjana Pickel, Lauren Simonova, Irina Lázár, Enikő Graham, Evan Jashari, Ramadan Andrä, Michaela Jeppsson, Anders Salehpour, Mehran Alkass, Kanar Druid, Henrik Kyriakopoulos, Christos P. Taleb, Iosif Shankar, Thirupura S. Selzman, Craig H. Sadek, Hesham Jovinge, Stefan Brusch, Lutz Frisén, Jonas Drakos, Stavros Bergmann, Olaf bioRxiv Article Cardiomyocytes in the adult human heart show a regenerative capacity, with an annual renewal rate around 0.5%. Whether this regenerative capacity of human cardiomyocytes is employed in heart failure has been controversial. Using retrospective (14)C birth dating we analyzed cardiomyocyte renewal in patients with end-stage heart failure. We show that cardiomyocyte generation is minimal in end-stage heart failure patients at rates 18–50 times lower compared to the healthy heart. However, patients receiving left ventricle support device therapy, who showed significant functional and structural cardiac improvement, had a >6-fold increase in cardiomyocyte renewal relative to the healthy heart. Our findings reveal a substantial cardiomyocyte regeneration potential in human heart disease, which could be exploited therapeutically. Cold Spring Harbor Laboratory 2023-09-17 /pmc/articles/PMC10515906/ /pubmed/37745322 http://dx.doi.org/10.1101/2023.09.14.557681 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which allows reusers to copy and distribute the material in any medium or format in unadapted form only, for noncommercial purposes only, and only so long as attribution is given to the creator.
spellingShingle Article
Derks, Wouter
Rode, Julian
Collin, Sofia
Rost, Fabian
Heinke, Paula
Hariharan, Anjana
Pickel, Lauren
Simonova, Irina
Lázár, Enikő
Graham, Evan
Jashari, Ramadan
Andrä, Michaela
Jeppsson, Anders
Salehpour, Mehran
Alkass, Kanar
Druid, Henrik
Kyriakopoulos, Christos P.
Taleb, Iosif
Shankar, Thirupura S.
Selzman, Craig H.
Sadek, Hesham
Jovinge, Stefan
Brusch, Lutz
Frisén, Jonas
Drakos, Stavros
Bergmann, Olaf
A latent cardiomyocyte regeneration potential in human heart disease
title A latent cardiomyocyte regeneration potential in human heart disease
title_full A latent cardiomyocyte regeneration potential in human heart disease
title_fullStr A latent cardiomyocyte regeneration potential in human heart disease
title_full_unstemmed A latent cardiomyocyte regeneration potential in human heart disease
title_short A latent cardiomyocyte regeneration potential in human heart disease
title_sort latent cardiomyocyte regeneration potential in human heart disease
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10515906/
https://www.ncbi.nlm.nih.gov/pubmed/37745322
http://dx.doi.org/10.1101/2023.09.14.557681
work_keys_str_mv AT derkswouter alatentcardiomyocyteregenerationpotentialinhumanheartdisease
AT rodejulian alatentcardiomyocyteregenerationpotentialinhumanheartdisease
AT collinsofia alatentcardiomyocyteregenerationpotentialinhumanheartdisease
AT rostfabian alatentcardiomyocyteregenerationpotentialinhumanheartdisease
AT heinkepaula alatentcardiomyocyteregenerationpotentialinhumanheartdisease
AT hariharananjana alatentcardiomyocyteregenerationpotentialinhumanheartdisease
AT pickellauren alatentcardiomyocyteregenerationpotentialinhumanheartdisease
AT simonovairina alatentcardiomyocyteregenerationpotentialinhumanheartdisease
AT lazareniko alatentcardiomyocyteregenerationpotentialinhumanheartdisease
AT grahamevan alatentcardiomyocyteregenerationpotentialinhumanheartdisease
AT jashariramadan alatentcardiomyocyteregenerationpotentialinhumanheartdisease
AT andramichaela alatentcardiomyocyteregenerationpotentialinhumanheartdisease
AT jeppssonanders alatentcardiomyocyteregenerationpotentialinhumanheartdisease
AT salehpourmehran alatentcardiomyocyteregenerationpotentialinhumanheartdisease
AT alkasskanar alatentcardiomyocyteregenerationpotentialinhumanheartdisease
AT druidhenrik alatentcardiomyocyteregenerationpotentialinhumanheartdisease
AT kyriakopouloschristosp alatentcardiomyocyteregenerationpotentialinhumanheartdisease
AT talebiosif alatentcardiomyocyteregenerationpotentialinhumanheartdisease
AT shankarthirupuras alatentcardiomyocyteregenerationpotentialinhumanheartdisease
AT selzmancraigh alatentcardiomyocyteregenerationpotentialinhumanheartdisease
AT sadekhesham alatentcardiomyocyteregenerationpotentialinhumanheartdisease
AT jovingestefan alatentcardiomyocyteregenerationpotentialinhumanheartdisease
AT bruschlutz alatentcardiomyocyteregenerationpotentialinhumanheartdisease
AT frisenjonas alatentcardiomyocyteregenerationpotentialinhumanheartdisease
AT drakosstavros alatentcardiomyocyteregenerationpotentialinhumanheartdisease
AT bergmannolaf alatentcardiomyocyteregenerationpotentialinhumanheartdisease
AT derkswouter latentcardiomyocyteregenerationpotentialinhumanheartdisease
AT rodejulian latentcardiomyocyteregenerationpotentialinhumanheartdisease
AT collinsofia latentcardiomyocyteregenerationpotentialinhumanheartdisease
AT rostfabian latentcardiomyocyteregenerationpotentialinhumanheartdisease
AT heinkepaula latentcardiomyocyteregenerationpotentialinhumanheartdisease
AT hariharananjana latentcardiomyocyteregenerationpotentialinhumanheartdisease
AT pickellauren latentcardiomyocyteregenerationpotentialinhumanheartdisease
AT simonovairina latentcardiomyocyteregenerationpotentialinhumanheartdisease
AT lazareniko latentcardiomyocyteregenerationpotentialinhumanheartdisease
AT grahamevan latentcardiomyocyteregenerationpotentialinhumanheartdisease
AT jashariramadan latentcardiomyocyteregenerationpotentialinhumanheartdisease
AT andramichaela latentcardiomyocyteregenerationpotentialinhumanheartdisease
AT jeppssonanders latentcardiomyocyteregenerationpotentialinhumanheartdisease
AT salehpourmehran latentcardiomyocyteregenerationpotentialinhumanheartdisease
AT alkasskanar latentcardiomyocyteregenerationpotentialinhumanheartdisease
AT druidhenrik latentcardiomyocyteregenerationpotentialinhumanheartdisease
AT kyriakopouloschristosp latentcardiomyocyteregenerationpotentialinhumanheartdisease
AT talebiosif latentcardiomyocyteregenerationpotentialinhumanheartdisease
AT shankarthirupuras latentcardiomyocyteregenerationpotentialinhumanheartdisease
AT selzmancraigh latentcardiomyocyteregenerationpotentialinhumanheartdisease
AT sadekhesham latentcardiomyocyteregenerationpotentialinhumanheartdisease
AT jovingestefan latentcardiomyocyteregenerationpotentialinhumanheartdisease
AT bruschlutz latentcardiomyocyteregenerationpotentialinhumanheartdisease
AT frisenjonas latentcardiomyocyteregenerationpotentialinhumanheartdisease
AT drakosstavros latentcardiomyocyteregenerationpotentialinhumanheartdisease
AT bergmannolaf latentcardiomyocyteregenerationpotentialinhumanheartdisease